Chief Commercial Officer of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a $6.79 billion market cap biopharmaceutical company whose stock has gained nearly 12% in the past week, recently sold 347 ...

Citi analyst David Lebowitz has maintained their bullish stance on MDGL stock, giving a Buy rating yesterday.Invest with Confidence: Follow ...

The transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units, as noted ...

Madrigal Pharmaceuticals (MDGL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yasmeen ...

Akero's success in reversing cirrhosis follows that of Madrigal, making analysts and investors bullish on drugs to treat ...

WEST CONSHOHOCKEN, PA—William John Sibold, the President and CEO of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), has sold shares of the company worth $531,020. The transaction involved the sale ...

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

Former “ Daily Show ” correspondent Al Madrigal returned on Thursday night with a stinging message about immigrants in the United States. “America doesn’t have an immigration policy,” he told Ronny ...

Disney On Ice” will make a return to the Hostess City, bringing two of the studio’s animated films to life. From February 28 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

One of President Trump's first executive orders impacts transgender inmates incarcerated in federal facilities. It's just one ...